Slaughter v. Scott, Unpublished Decision (3-15-1999)

CourtOhio Court of Appeals
DecidedMarch 15, 1999
DocketCase No. 98 CA 2591
StatusUnpublished

This text of Slaughter v. Scott, Unpublished Decision (3-15-1999) (Slaughter v. Scott, Unpublished Decision (3-15-1999)) is published on Counsel Stack Legal Research, covering Ohio Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Slaughter v. Scott, Unpublished Decision (3-15-1999), (Ohio Ct. App. 1999).

Opinion

This is an appeal from a judgment entered by the Scioto County Commom Pleas Court, upon a jury verdict, finding in favor the Kroger Company (hereinafter referred to as "Kroger"), defendant below and appellee herein, on the claims brought against it by James Slaughter and Joann Slaughter, plaintiffs below and appellants herein. The following error has been assigned for our review:

"THE TRIAL COURT ERRED IN PERMITTING DEFENDANT-APPELLEE TO USE A 1995 VIDEO CROSS-EXAMINATION OF PLAINTIFF-APPELLANT'S DOCTOR AS AND FOR DEFENDANT-APPELLEE'S CROSS-EXAMINATION OF PLAINTIFF-APPELLANTS DOCTOR WHEN SAID DOCTOR WAS TESTIFYING LIVE AT THE TRIAL IN 1998. THE 1995 DEPOSITION WAS A VIDEO DEPOSITION OF THE CROSS-EXAMINATION OF PLAINTIFF-APPELLANT'S DOCTOR PLAYED BACK IN ITS ENTIRETY TO THE JURY WHICH CONFUSED THE JURY BECAUSE THE DOCTOR'S TESTIMONY WAS SIGNIFICANTLY CHANGED IN 1998 BECAUSE THE DOCTOR COULD CLAIM THAT THE INJURIES THAT THE PLAINTIFF-APPELLANT SUSTAINED HAD COME TO FRUITION IN 1998 WHEN IN 1995 THE COMPLICATIONS THE PLAINTIFF -APPELLANT WOULD HAVE HAD NOT REVEALED THEMSELVES."

The record reveals the following facts pertinent to the case at bar. Appellant, James Slaughter, was diagnosed with diabetes in the late 1980s. He was placed on various oral hypoglycemic agents which, for a while, managed to keep the disease at manageable levels. However, by 1991 his blood sugar "flared up and was running high" which prompted his referral to Dr. George Borst, M.D., an internist specializing in endocrinology. Dr. Borst treated appellant's diabetes, in part, by prescribing a sulfonylurea drug known as Glynase Prestabs (hereinafter referred to as "Glynase").

On January 25, 1994, either Mr. Slaughter or his wife, Appellant Joann Slaughter, went to the pharmacy at Kroger in Wheelersburg, Ohio, to obtain a refill of his Glynase prescription. The prescribed dosage of this drug by Dr. Borst was three (3) milligrams but, inadvertently, the Kroger pharmacist dispensed pills containing twice that amount or six (6) milligrams. Mr. Slaughter took this medication for almost a month before the mistake was discovered. During that time, he developed urticaria (hives), angioedema (swelling) and respiratory distress. Since then, his diabetes has worsened to a point where he is now insulin dependent.

Appellants first brought suit against Kroger and other various defendants in 1995 but ultimately dismissed their case the following year after an adverse evidentiary ruling. They refiled the action as the cause sub judice on December 30, 1996, alleging that the pharmacist negligently filled the prescription and that Kroger was liable for that negligence under the doctrine of respondeat superior. Such malfeasance, they asserted, led to "numerous failings" of "bodily functions" including cessation of insulin production in the pancreas thereby requiring Mr. Slaughter to have daily insulin injections. Appellants demanded compensatory damages for these injuries, as well as resultant medical expenses and loss of consortium, in excess of $2,000,000. Kroger filed an answer admitting that the prescription was mistakenly filled and that its pharmacist was operating within the scope of her employment at the time. Appellee denied liability, however, on the claim(s) brought against it and asserted inter alia that Mr. Slaughter's injuries were the result of his "own acts or omissions."

On March 5, 1997, the parties filed a joint stipulation agreeing "that all discovery completed in the first action shall be . . . transferred and effective in this refiled litigation." Specifically, they agreed that all videotaped depositions from the previous lawsuit could be used in this one. As the case got closer to trial, however, appellants grew increasingly concerned about the use of those prior depositions. On March 13, 1998, they filed a motionin limine asking the trial court to restrict appellee to the use of "any one (1) deposition, or any one (1) videotape, or the live testimony of any doctor herein" but not "bits and pieces of the same." Otherwise, appellants concluded, the use of selected portions of previous depositions "would be to[o] arduous and delay the trial significantly" and could "create a false image of the testimony previously taken." This motion was overruled by the trial court a week later.

The matter proceeded to a jury trial on March 23, 1998, at which time appellants adduced uncontroverted evidence of Mr. Slaughter's diminished physical capacities, and the progressive worsening of his diabetes, since taking the erroneously filled prescription. Appellee did not really contest Mr. Slaughter's then existing physical condition but, rather, argued that the double dosage of Glynase was not the proximate cause of his various medical problems. This contested issue of causation centered largely on the expert testimony of three (3) physicians. Dr. E.V. Gevedon, M.D., an allergist and immunologist, treated Mr. Slaughter for the hives and swelling that he suffered after ingesting the Glynase. It was the expert opinion of Dr. Gevedon that the double dosage of this drug offered "considerable explanation" for appellant's allergic reaction. The witness further opined that, to a reasonable degree of medical certainty, such allergic reaction caused Mr. Slaughter's pancreas to quit functioning appropriately. This opinion was corroborated by the testimony of Dr. Borst, appellant's endocrinologist, who related that Mr. Slaughter's "diabetic control ha[d] changed significantly for the worse since that time." Dr. Borst also opined that, to a reasonable degree of medical certainty, the "allergic reaction to the overdose of [G]lynase . . . damaged [appellant's] pancreas." The witness continued and explained that the double dosage of medication had rendered his patient "insulin dependent," whereas before Mr. Slaughter had been "non insulin dependent," and shortened his life span. Dr. Borst further testified that in the future Mr. Slaughter would develop eye and kidney problems as well as "neuropathy" and heightened sensitivity to pain.

There was also substantial evidence adduced to show that the double dosage of Glynase had little, if any, effect on Mr. Slaughter's deteriorating health. First, it was uncontroverted that he was very overweight at 6'1" and 280 lbs. His ideal body weight was described as being, approximately, 190 lbs. Dr. Borst placed appellant on a strict 1,800 calorie per day diet but this regimen was only "moderately" followed. It was also recommended that he get more exercise but this advice, likewise, went unheeded. The experts testifying on this point below were virtually unanimous in their opinion that even a modest weight loss of 15 lbs. would have yielded a significant improvement in managing appellant's diabetes. However, Mr. Slaughter's weight has remained relatively constant (around 275-280 lbs.) since the mid 1980s.

During the course of the trial, Dr. Borst was also cross-examined with the use of a video-taped deposition that he had given in the previous lawsuit. Portions of that deposition seem to contradict some of the statements he made during his direct testimony and included opinions that (1) an allergic reaction to Glynase can occur at any time, regardless of the dosage given, (2) increased dosages of Glynase would not necessarily lead to loss of control over blood sugar, (3) the problems experienced by Mr. Slaughter could be related to stress which he experienced after discovering that he was taking a double dosage of the medication, and (4) increased dosages of Glynase will not have "a direct or toxic effect on the pancreas." Dr. Borst also testified during the video-taped deposition that it was impossible to tell, at that time, what if any additional complications Mr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Steiner v. Custer
31 N.E.2d 855 (Ohio Supreme Court, 1940)
State v. Stanton
239 N.E.2d 92 (Ohio Supreme Court, 1968)
Suchy v. Moore
279 N.E.2d 878 (Ohio Supreme Court, 1972)
State v. Freeman
485 N.E.2d 1043 (Ohio Supreme Court, 1985)
State v. Sage
510 N.E.2d 343 (Ohio Supreme Court, 1987)
State v. Brown
528 N.E.2d 523 (Ohio Supreme Court, 1988)
Berk v. Matthews
559 N.E.2d 1301 (Ohio Supreme Court, 1990)
In re Jane Doe 1
566 N.E.2d 1181 (Ohio Supreme Court, 1991)
Rigby v. Lake County
569 N.E.2d 1056 (Ohio Supreme Court, 1991)
Peters v. Ohio State Lottery Commission
587 N.E.2d 290 (Ohio Supreme Court, 1992)
Buchman v. Board of Education
652 N.E.2d 952 (Ohio Supreme Court, 1995)
Malone v. Courtyard by Marriott Ltd. Partnership
659 N.E.2d 1242 (Ohio Supreme Court, 1996)
State v. Hill
661 N.E.2d 1068 (Ohio Supreme Court, 1996)
Nakoff v. Fairview General Hospital
662 N.E.2d 1 (Ohio Supreme Court, 1996)
Landis v. Grange Mutual Insurance
695 N.E.2d 1140 (Ohio Supreme Court, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
Slaughter v. Scott, Unpublished Decision (3-15-1999), Counsel Stack Legal Research, https://law.counselstack.com/opinion/slaughter-v-scott-unpublished-decision-3-15-1999-ohioctapp-1999.